Misoprostol acid

[ Density]:
1.1±0.1 g/cm3

[ Boiling Point ]:
538.3±50.0 °C at 760 mmHg

[ Molecular Formula ]:
C₂₁H₃₆O₅

[ Molecular Weight ]:
368.508

[ Flash Point ]:
293.4±26.6 °C

[ Exact Mass ]:
368.256287

[ PSA ]:
94.83000

[ LogP ]:
2.45

[ Vapour Pressure ]:
0.0±3.2 mmHg at 25°C

[ Index of Refraction ]:
1.543

[ Storage condition ]:
−20°C

[ Symbol ]:

GHS06, GHS08

[ Signal Word ]:
Danger

[ Hazard Statements ]:
H301-H315-H319-H335-H361

[ Precautionary Statements ]:
P261-P281-P301 + P310-P305 + P351 + P338

[ Hazard Codes ]:
T: Toxic;

[ Risk Phrases ]:
R45

[ Safety Phrases ]:
53-22-36/37/39-45

[ RIDADR ]:
UN 2810 6

[ WGK Germany ]:
2

Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage.

J. Obstet. Gynaecol. Can. 31 , 980-993, (2009)

To review the clinical aspects of postpartum hemorrhage (PPH) and provide guidelines to assist clinicians in the prevention and management of PPH. These guidelines are an update from the previous Soci...

Management of NSAID-induced gastrointestinal toxicity: focus on proton pump inhibitors.

Drugs 69 , 51-69, (2009)

The association between NSAIDs and the presence of upper gastrointestinal (GI) complications is well established. Evidence that acid aggravates NSAID-induced injury provides a rationale for minimizing...

Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial.

Lancet 2 , 1277, (1988)

A double-blind, placebo-controlled study was carried out to see whether the synthetic E prostaglandin, misoprostol, would prevent gastric ulcer induced by non-steroidal anti-inflammatory drugs (NSAIDs...

More Articles